Acarodermatitis and Appetite - decreased

Summary:

Appetite - decreased is found among people with Acarodermatitis, especially for people who are male, 60+ old.

The study analyzes which people have Appetite - decreased with Acarodermatitis. It is created by eHealthMe based on reports of 19 people who have Acarodermatitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 212 drugs and 310 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,554 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.



On Jul, 15, 2026

19 people who have Acarodermatitis and Appetite - Decreased are studied.

Would you have Appetite - decreased when you have Acarodermatitis?

Gender of people who have Acarodermatitis and experienced Appetite - Decreased *:

  • female: 42.11 %
  • male: 57.89 %

Age of people who have Acarodermatitis and experienced Appetite - Decreased *:

  • 0-1: 0.0 %
  • 2-9: 13.33 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 6.67 %
  • 40-49: 0.0 %
  • 50-59: 6.67 %
  • 60+: 66.67 %

Common co-existing conditions for these people *:

  1. Itching: 4 people, 21.05%
  2. Weight Decreased: 1 person, 5.26%
  3. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 5.26%
  4. Arteriosclerosis Of The Extremities (thickening and hardening of arteries- legs and feet): 1 person, 5.26%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.26%
  6. Constipation: 1 person, 5.26%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.26%
  8. Gastric Ulcer (stomach ulcer): 1 person, 5.26%
  9. Gastritis (inflammation of stomach): 1 person, 5.26%
  10. High Blood Pressure: 1 person, 5.26%

Common drugs taken by these people *:

  1. Stromectol: 10 people, 52.63%
  2. Eurax: 4 people, 21.05%
  3. Cozaar: 2 people, 10.53%
  4. Permethrin: 2 people, 10.53%
  5. Vyvanse: 1 person, 5.26%
  6. Kwell: 1 person, 5.26%
  7. Colace: 1 person, 5.26%
  8. Diclofenac: 1 person, 5.26%
  9. Dipyrone: 1 person, 5.26%
  10. Ivermectin: 1 person, 5.26%

Common symptoms for these people *:

  1. Nausea And Vomiting: 6 people, 31.58%
  2. Nausea (feeling of having an urge to vomit): 4 people, 21.05%
  3. Dehydration (dryness resulting from the removal of water): 4 people, 21.05%
  4. Pain: 3 people, 15.79%
  5. Death: 3 people, 15.79%
  6. Depressed Level Of Consciousness: 3 people, 15.79%
  7. Pain In Extremity: 3 people, 15.79%
  8. Hypersensitivity: 3 people, 15.79%
  9. Fatigue (feeling of tiredness): 3 people, 15.79%
  10. Weight Decreased: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Appetite - decreased:

All the conditions that are associated with Appetite - decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Appetite - decreased and Acarodermatitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: